NeoGenomics
在场
NeoGenomics 是一家在股票代码 NEO (US) 下上市的公司。
高管
查看带有其 32 名主要高管的组织结构图
NeoGenomics 搜索最多的简介
- Chris Smith, Chief Executive Officer and Director
- Lynn Tetrault, Non-Executive Chairman of the Board
- Alison Hannah, Director
高管在NeoGenomics变化
- Felicia Williams已作为Member of the Board加入公司 (新闻发布的2024十一月5号).
- Vishal Sikri, President, Advanced Diagnostics Division 请很快离开公司 (新闻发布的2024四月21号).
- Warren Stone 曾任 President, Clinical Division, 现升职为 Chief Commercial Officer (新闻发布的2024四月19号).
创建提醒
跟踪 NeoGenomics 的高管变动
健康
NeoGenomics 拥有 1,965 家竞争者，其中包括 Siemens Healthineers (德国)、IQVIA (美国(美洲)) 和 Nestlé Health Science (瑞士)。
Popular M&A news in 健康
- Radon Medical Imaging 已收购 Alpha Imaging (公布2024十一月20号).
- TowerBrook Capital Partners 已收购 R1 RCM (公布2024十一月19号).
- Kewaunee Scientific 已收购 Nu Aire (公布2024十一月6号).
健康 行业的其他推荐联系人
消息
NeoGenomics 的最新新闻稿
- Felicia Williams Joins NeoGenomics Board of Directors
- NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
- NeoGenomics Reports Third Quarter 2024 Results
- NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test
- NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024
- NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia
- NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation
- Press Release | NeoGenomics Laboratories
- NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
- NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- View more press releases Close
关于 NeoGenomics 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Chris Smith 
